Explore our detailed Claude AI review, highlighting its features, performance, and user experience. Make an informed choice ...
Abstract: Excessive screen time has become a global concern with potential implications on the behavioral and academic outcomes of youth. In this study, we analyze a dataset of children aged 5–15 to ...
In 2016, Sundar Pichai told his employees that Google was going to be an “AI-first company.” At the time, the statement struck some as a nonevent and others as premature: the investments in and ...
Pillay is an editorial fellow at TIME. Pillay is an editorial fellow at TIME. AI now helps people with wedding toasts, tax returns, and processing the trauma of war. The technology’s generality lets ...
Abstract: Financial crime is increasingly facilitated by technology and globalization, demanding advanced IT tools for detection. This paper presents an approach to automate the detection of ...
WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the agency to monitor clinical trial data in real time, a step the agency ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.
Mr. Mullick served in the Department of Defense Office of Inspector General from 2016 to 2026. See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results